Helius signs agreement with Enwave for next-gen drying technology

Updated: Dec 19, 2019

EnWave Corporation (TSX-V:ENW | FSE:E4U) has signed an exclusive, royalty-bearing commercial license with Helius Therapeutics in New Zealand to use its proprietary drying technology.



Enwave technology provides Helius with the ability to unlock new medicinal cannabis product opportunities with innovative drying and dehydration technology. The company's

REV™ technology allows for rapid, gentle drying that preserves active components of cannabis while allows for extreme precision over the final moisture content, enabling a long shelf life. Importantly, the technology helps to preserve cannabinoids, terpenes, flavonoids and other therapeutic compounds in cannabis


Helius is New Zealand's largest licensed medical cannabis company with a strong focus on research and development. It is also the first cannabis company in the world to be certified as New Zealand Grown. Helius has a state-of-the-art biotechnology facility in Auckland, New Zealand, with large-scale indoor controlled growing systems, integrated extraction site, an advanced cannabinoid research laboratory and manufacturing operations. The License grants Helius the exclusive right to use EnWave’s proprietary Radiant Energy Vacuum (“REVTM”) dehydration technology for the drying of cannabis in New Zealand with the ability to sublicense to additional third-party Cannabis companies.


Pursuant to the License, Helius has purchased a 10kW REV machine to use REV technology for commercial production of dehydrated medicinal cannabis. Under the terms of the License, Helius will pay EnWave a usage-based royalty based on the weight of cannabis dried using the REV machine. The other terms of the License, including the terms of the sub-licensing rights, are not disclosed.


This is the seventh commercial royalty-bearing license for cannabis processing granted by EnWave, and the first and only to be granted in New Zealand. EnWave has granted royalty-bearing commercial licenses for cannabis dehydration in Canada, Europe, Australia and New Zealand.


About EnWave


EnWave Corporation, a Vancouver-based advanced technology company, has developed Radiant Energy Vacuum (REV) – an innovative, proprietary method for the precise dehydration of organic materials. EnWave has further developed patent-pending methods for uniformly drying and decontaminating cannabis through the use of REV technology, shortening the time from harvest to marketable cannabis products.


REV technology’s commercial viability has been demonstrated and is growing rapidly across several market verticals in the food, and pharmaceutical sectors including legal cannabis. EnWave’s strategy is to sign royalty-bearing commercial licenses with industry leaders in multiple verticals for the use of REV technology. The company has signed over twenty royalty-bearing licenses to date, opening up nine distinct market sectors for commercialisation of new and innovative products. In addition to these licenses, EnWave has formed a Limited Liability Corporation, NutraDried Food Company, LLC, to develop, manufacture, market and sell all-natural cheese snack products in the United States under the Moon Cheese® brand.


EnWave has introduced REVTM as the new dehydration standard in the food and biological material sectors: faster and more efficient than freeze drying, with better end product quality than air drying or spray drying.


EnWave currently has three commercial REV platforms:


  1. nutraREV® which is used in the food industry to dry food products quickly and at low-cost, while maintaining high levels of nutrition, taste, texture and colour;

  2. powderREV® which is used for the bulk dehydration of food cultures, probiotics and fine biochemicals such as enzymes below the freezing point, and

  3. quantaREV® which is used for continuous, high-volume low-temperature drying.

  4. An additional platform, freezeREV , is being developed as a new method to stabilise and dehydrate biopharmaceuticals such as vaccines and antibodies.

More information about EnWave is available at www.enwave.net


0 views

© Helius Therapeutics 2018